Lingna Hu

432 total citations
11 papers, 277 citations indexed

About

Lingna Hu is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, Lingna Hu has authored 11 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Genetics. Recurrent topics in Lingna Hu's work include CRISPR and Genetic Engineering (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Lingna Hu is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Endoplasmic Reticulum Stress and Disease (2 papers). Lingna Hu collaborates with scholars based in China, Singapore and United States. Lingna Hu's co-authors include Daru Lu, Hongyan Chen, Hyung‐Ho Ha, Young‐Tae Chang, Hee-Sung Park, Haiyan Ren, Christian Hoppmann, Lei Wang, Dongdong Su and Eduardo Peña‐Cabrera and has published in prestigious journals such as Nature Communications, Journal of Chromatography A and Gene.

In The Last Decade

Lingna Hu

11 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingna Hu China 10 155 46 32 31 30 11 277
Long Ye China 12 161 1.0× 78 1.7× 19 0.6× 23 0.7× 37 1.2× 36 356
Shinsaku Nakagawa Japan 9 161 1.0× 53 1.2× 26 0.8× 27 0.9× 37 1.2× 31 312
Gabriele Raciti Italy 7 156 1.0× 39 0.8× 28 0.9× 20 0.6× 41 1.4× 12 298
Agata A. Bielska United States 10 252 1.6× 43 0.9× 30 0.9× 8 0.3× 28 0.9× 13 357
Philbert Lee United States 8 323 2.1× 56 1.2× 39 1.2× 30 1.0× 29 1.0× 9 503
Anat Shahar Israel 13 268 1.7× 35 0.8× 31 1.0× 35 1.1× 21 0.7× 25 401
Amanda Cobos‐Correa Switzerland 6 192 1.2× 43 0.9× 42 1.3× 50 1.6× 33 1.1× 9 385
Miao Zhong China 11 218 1.4× 44 1.0× 41 1.3× 46 1.5× 32 1.1× 20 379
Zhiqiang Ren China 12 154 1.0× 47 1.0× 27 0.8× 26 0.8× 41 1.4× 33 326

Countries citing papers authored by Lingna Hu

Since Specialization
Citations

This map shows the geographic impact of Lingna Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingna Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingna Hu more than expected).

Fields of papers citing papers by Lingna Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingna Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingna Hu. The network helps show where Lingna Hu may publish in the future.

Co-authorship network of co-authors of Lingna Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingna Hu. A scholar is included among the top collaborators of Lingna Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingna Hu. Lingna Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hu, Lingna, et al.. (2018). Intracellular generation of single-strand template increases the knock-in efficiency by combining CRISPR/Cas9 with AAV. Molecular Genetics and Genomics. 293(4). 1051–1060. 13 indexed citations
2.
Wang, Hongxiang, Xiao Song, Qilin Huang, et al.. (2018). LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis. Cancer Epidemiology Biomarkers & Prevention. 28(4). 760–769. 32 indexed citations
3.
Jia, Chenqiang, Cong Huai, Jiaqi Ding, et al.. (2017). New applications of CRISPR/Cas9 system on mutant DNA detection. Gene. 641. 55–62. 27 indexed citations
4.
Zhao, Yingjie, Dapeng Yun, Xiang Zou, et al.. (2017). Whole exome-wide association study identifies a missense variant in SLC2A4RG associated with glioblastoma risk.. PubMed. 7(9). 1937–1947. 13 indexed citations
5.
Su, Dongdong, Haiyan Ren, Lingna Hu, et al.. (2016). Development of background-free tame fluorescent probes for intracellular live cell imaging. Nature Communications. 7(1). 11964–11964. 100 indexed citations
6.
Zhao, Yingjie, Gong� Chen, Hongjie Yu, et al.. (2016). Development of risk prediction models for glioma based on genome-wide association study findings and comprehensive evaluation of predictive performances. Oncotarget. 9(9). 8311–8325. 4 indexed citations
7.
Fan, Lu, Lingna Hu, Xianying Fang, et al.. (2014). Erlotinib promotes endoplasmic reticulum stress-mediated injury in the intestinal epithelium. Toxicology and Applied Pharmacology. 278(1). 45–52. 20 indexed citations
8.
Meng, Delong, Yuanyuan Chen, Dapeng Yun, et al.. (2014). High expression of N-myc (and STAT) interactor predicts poor prognosis and promotes tumor growth in human glioblastoma. Oncotarget. 6(7). 4901–4919. 27 indexed citations
9.
Hu, Lingna, Xianying Fang, Hailiang Liu, et al.. (2014). Protective effects of 18β-glycyrrhetinic acid on LPS-induced injury in intestinal epithelial cells. Chinese Journal of Natural Medicines. 11(1). 24–29. 12 indexed citations
10.
Hu, Lingna, Xianying Fang, Hailiang Liu, et al.. (2013). Protective effects of 18β-glycyrrhetinic acid on LPS-induced injury in intestinal epithelial cells. Chinese Journal of Natural Medicines. 11(1). 24–29. 13 indexed citations
11.
Hu, Lingna, et al.. (2013). Membrane assisted micro-solid phase extraction of pharmaceuticals with amino and urea-grafted silica gel. Journal of Chromatography A. 1316. 8–14. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026